SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001570562-24-000072
Filing Date
2024-04-26
Accepted
2024-04-26 16:55:57
Documents
18
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A eols2024definitiveproxy.htm DEF 14A 912255
2 bradystewartheadshota.jpg GRAPHIC 2890507
3 chart-02656b0f138841a1800a.jpg GRAPHIC 24902
4 chart-bfb5f1237a944d19853a.jpg GRAPHIC 24548
5 chart-f078810408ca43c7826a.jpg GRAPHIC 78977
6 chart-f2e4be89f6474804865a.jpg GRAPHIC 79369
7 chart-fa1a5687b72a4a3faa3a.jpg GRAPHIC 19695
8 davidgillheadshota.jpg GRAPHIC 3378461
9 davidmoatazediheadshota.jpg GRAPHIC 3682815
10 dmsignaturea.jpg GRAPHIC 5036
11 evolus23registereda.jpg GRAPHIC 12793
12 finalproxycard_pagex1a.jpg GRAPHIC 940026
13 finalproxycard_pagex2a.jpg GRAPHIC 774687
14 image12.jpg GRAPHIC 8908
15 karahparschauerheadshota.jpg GRAPHIC 2383572
16 roberthaymanheadshota.jpg GRAPHIC 3131715
17 simoneblankheadshota.jpg GRAPHIC 2814107
18 vikrammalikheadshota.jpg GRAPHIC 3191079
  Complete submission text file 0001570562-24-000072.txt   33157472
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38381 | Film No.: 24884834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)